ANAPTYSBIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21 USD | +11.29% |
|
+5.69% | -1.96% |
| Apr. 16 | Leerink Partners Starts AnaptysBio With Outperform Rating, $47 Price Target | MT |
| Apr. 11 | Wells Fargo Initiates AnaptysBio With Overweight Rating, $56 Price Target | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bullish |
| Resistance | 21.47 | 26.47 | 25.87 |
| Spread/Res. | -2.19% | -20.66% | -18.82% |
| Spread/Supp. | +11.29% | +51.62% | +9.09% |
| Support | 18.87 | 13.85 | 19.25 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ANAB Stock
- Charts AnaptysBio, Inc.
